1. Holman RC, Stoll BJ, Curns AT, Yorita KL, Steiner
CA, Schonberger LB. Necrotising enterocolitis hospitalisations among
neonates in the United States. Paediatr Perinat Epidemiol. 2006;20(6):498-506.
2. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet. 2006;368(9543):1271-1283.
3. Maayan-Metzger A, Itzchak A, Mazkereth R, Kuint J. Necrotizing
enterocolitis in full-term infants: case-control study and review
of the literature. J Perinatol. 2004;24(8):494-499.
4. Ng S. Necrotizing enterocolitis in the full-term neonate. J
Paediatr Child Health. 2001;37(1):1-4.
5. Horbar JD, Badger GJ, Carpenter JH, et al. Trends in mortality
and morbidity for very low birth weight infants, 1991-1999. Pediatrics. 2002;110(1
Pt 1):143-151.
6. Sankaran K, Puckett B, Lee DS, et al. Variations in incidence
of necrotizing enterocolitis in Canadian neonatal intensive care
units. J Pediatr Gastroenterol Nutr. 2004;39(4):366-372.
7. Pietz J, Achanti B, Lilien L, Stepka EC, Mehta SK. Prevention
of necrotizing enterocolitis in preterm infants: a 20-year experience. Pediatrics. 2007;119(1):e164-e170.
8. Uauy RD, Fanaroff AA, Korones SB, Phillips EA,
Phillips JB, Wright LL. Necrotizing enterocolitis in very low birth
weight infants: biodemographic and clinical correlates. National
Institute of Child Health and Human Development Neonatal Research
Network. J Pediatr. 1991;119(4):630-638.
9. Neu J, Chen M, Beierle E. Intestinal innate immunity: How
does it relate to the pathogenesis of necrotizing enterocolitis? Semin
Pediatr Surg. 2005;14(3):137-144.
10. Luig M, Lui K. Epidemiology of necrotizing enterocolitis.
Part II: Risks and susceptibility of premature infants during the
surfactant era: a regional study. J Paediatr Child Health. 2005;41
(4):174-179.
11. Blakely ML, Lally KP, McDonald S, et al. Postoperative outcomes
of extremely low birth-weight infants with necrotizing enterocolitis
or isolated intestinal perforation: a prospective cohort study by
the NICHD Neonatal Research Network. Ann Surg. 2005;241(6):984-989;
discussion 989-994.
12. Llanos AR, Moss ME, Pinzon MC, Dye T, Sinkin
RA, Kendig JW. Epidemiology of neonatal necrotising enterocolitis:
a population-based study. Paediatr Perinat Epidemiol. 2002;16(4):342-349.
13. Fanaroff AA, Hack M, Walsh MC. The NICHD neonatal research
network: changes in practice and outcomes during the first 15 years. Semin Perinatol. 2003;27(4):281-287.
14. Holman RC, Stoll BJ, Clarke MJ, Glass RI. The epidemiology
of necrotizing enterocolitis infant mortality in the United States. Am
J Public Health. 1997;87(12):2026-2031.
15. Wilson-Costello D, Friedman H, Minich N, et al.
Improved neurodevelopmental outcomes for extremely low birth weight
infants in 2000-2002. Pediatrics. 2007;119(1):37-45.
16. Guillet R, Stoll BJ, Cotten CM, et al. Association of H2-blocker
therapy and higher incidence of necrotizing enterocolitis in very
low birth weight infants. Pediatrics. 2006;117(2):e137-e142.
17. Guthrie SO, Gordon PV, Thomas V, Thorp JA, Peabody
J, Clark RH. Necrotizing enterocolitis among neonates in the United
States. J Perinatol. 2003;23(4):278-285.
18. Warner B, Ryan AL, Seeger K, Leonard AC, Erwin CR, Warner
BW. Ontogeny of salivary epidermal growth factor and necrotizing
enterocolitis. J Pediatr. 2007;150(4):358-363.
19. Meyers RL, Alpan G, Lin E, Clyman RI. Patent ductus
arteriosus,
indomethacin, and intestinal distension: effects on
intestinal blood flow and oxygen consumption.
Pediatr Res. 1991;29(6):569-574.
20. Neu J W-WC. Eicosanoids in the developing gastrointestinal
tract.
Semin Perinatol. 1987;11:22-30.
[PubMed: 3551082]
21. King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX)
inhibitors for treating preterm labour. Cochrane Database
Syst Rev. 2005;(2):CD001992.
22. Amin SB, Sinkin RA, Glantz JC. Metaanalysis of the effect
of antenatal
indomethacin on neonatal outcomes.
Am J Obstet
Gynecol. 2007;197(5):486 e481-e410.
23. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating
fetal lung maturation for women at risk of preterm birth. Cochrane
Database Syst Rev. 2006;(3):CD004454.
24. Barrington KJ. Umbilical artery catheters in the newborn:
effects of position of the catheter tip. Cochrane Database
Syst Rev. 2000;(2):CD000505.
25. Fowlie PW, Davis PG. Prophylactic intravenous
indomethacin
for preventing mortality and morbidity in preterm infants.
Cochrane
Database Syst Rev. 2002;(3):CD000174.
26. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas
AS. Effects of
indomethacin in premature infants with patent ductus
arteriosus: results of a national collaborative study.
J
Pediatr. 1983;102(6):895-906.
27. Kafetzis DA, Skevaki C, Costalos C. Neonatal necrotizing
enterocolitis: an overview. Curr Opin Infect Dis. 2003;16(4):349-355.
28. Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment
with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus
in preterm infants. Cochrane Database Syst Rev. 2008;(1):CD003951.
29. Ohlsson A, Walia R, Shah S.
Ibuprofen for the treatment
of patent ductus arteriosus in preterm and/or low birth
weight infants.
Cochrane Database Syst Rev. 2008;(1):CD003481.
30. Shah SS, Ohlsson A.
Ibuprofen for the prevention of patent
ductus arteriosus in preterm and/or low birth weight infants.
Cochrane
Database Syst Rev. 2006;(1):CD004213.
31. Lambert DK, Christensen RD, Henry E, et al. Necrotizing
enterocolitis in term neonates: data from a multihospital health-care
system. J Perinatol. 2007;27(7):437-443.
32. Martinez-Tallo E, Claure N, Bancalari E. Necrotizing enterocolitis
in full-term or near-term infants: risk factors. Biol Neonate. 1997;71(5):292-298.
33. McElhinney DB, Hedrick HL, Bush DM, et al. Necrotizing enterocolitis
in neonates with congenital heart disease: risk factors and outcomes. Pediatrics. 2000;106(5):1080-1087.
34. Ostlie DJ, Spilde TL, St Peter SD, et al. Necrotizing enterocolitis
in full-term infants. J Pediatr Surg. 2003;38(7):1039-1042.
35. Santulli TV, Schullinger JN, Heird WC, et al. Acute necrotizing
enterocolitis in infancy: a review of 64 cases. Pediatrics. 1975;55(3):376-387.
36. Kosloske AM. A unifying hypothesis for pathogenesis and
prevention of necrotizing enterocolitis. J Pediatr. 1990;117(1
Pt 2):S68-S74.
37. Grave GD, Nelson SA, Walker WA, et al. New therapies and
preventive approaches for necrotizing enterocolitis: report of a
research planning workshop. Pediatr Res. 2007;62(4):510-514.
38. Jilling T, Simon D, Lu J, et al. The roles of bacteria and
TLR4 in rat and murine models of necrotizing enterocolitis. J
Immunol. 2006;177(5):3273-3282.
39. Musemeche CA, Kosloske AM, Bartow SA, Umland
ET. Comparative effects of ischemia, bacteria, and substrate on
the pathogenesis of intestinal necrosis. J Pediatr Surg. 1986;21(6):536-538.
40. Willoughby RE Jr, Pickering LK. Necrotizing enterocolitis
and infection. Clin Perinatol. 1994;21(2):307-315.
41. Peter CS, Feuerhahn M, Bohnhorst B, et al. Necrotising enterocolitis:
Is there a relationship to specific pathogens? Eur J Pediatr. 1999;158(1):67-70.
42. Millar MR, Linton CJ, Cade A, Glancy D, Hall M, Jalal H.
Application of 16S rRNA gene PCR to study bowel flora of preterm
infants with and without necrotizing enterocolitis. J Clin
Microbiol. 1996;34(10):2506-2510.
43. Claud EC, Walker WA. Hypothesis: inappropriate colonization
of the premature intestine can cause neonatal necrotizing enterocolitis. Faseb J. 2001;15(8):1398-1403.
44. Gewolb IH, Schwalbe RS, Taciak VL, Harrison TS,
Panigrahi P. Stool microflora in extremely low birthweight infants. Arch
Dis Child Fetal Neonatal Ed. 1999;80(3):F167-G173.
45. Xu J, Gordon JI. Inaugural article: honor thy symbionts.
Proc
Natl Acad Sci U S A. 2003; 100(18):10452-10459.
[PubMed: 12923294]
46. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation
of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl
Acad Sci U S A. 2002;99(24):15451-15455.
47. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S,
Medzhitov R. Recognition of commensal microflora by toll-like receptors
is required for intestinal homeostasis. Cell. 23 2004;118(2):229-241.
48. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammation
in the developing human intestine: A possible pathophysiologic contribution
to necrotizing enterocolitis. Proc Natl Acad Sci U S A. 2000;97(11):6043-6048.
49. Lotz M, Gutle D, Walther S, Menard S, Bogdan C,
Hornef MW. Postnatal acquisition of endotoxin tolerance in intestinal
epithelial cells. J Exp Med. 2006;203(4):973-984.
50. Fusunyan RD, Nanthakumar NN, Baldeon ME, Walker WA. Evidence
for an innate immune response in the immature human intestine: toll-like
receptors on fetal enterocytes. Pediatr Res. 2001;49(4):589-593.
51. De Plaen IG, Liu SX, Tian R, et al. Inhibition of nuclear
factor-kappaB ameliorates bowel injury and prolongs survival in
a neonatal rat model of necrotizing enterocolitis. Pediatr
Res. 2007;61(6):716-721.
52. Chung DH, Ethridge RT, Kim S, et al. Molecular mechanisms
contributing to necrotizing enterocolitis. Ann Surg. 2001;233(6):835-842.
53. Le Mandat Schultz A, Bonnard A, Barreau F, et al. Expression
of TLR-2, TLR-4, NOD2 and pNF-kappaB in a neonatal rat model of
necrotizing enterocolitis. PLoS ONE. 2007;2(10):e1102.
54. Leaphart CL, Cavallo J, Gribar SC, et al. A critical role
for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating
intestinal injury and repair. J Immunol. 2007;179(7):4808-4820.
55. Markel TA, Crisostomo PR, Wairiuko GM, Pitcher J, Tsai BM,
Meldrum DR. Cytokines in necrotizing enterocolitis. Shock. 2006;25(4):329-337.
56. Ford H, Watkins S, Reblock K, Rowe M. The role of inflammatory
cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J
Pediatr Surg. 1997;32(2):275-282.
57. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and
counterinflammatory cytokine levels and severity in necrotizing
enterocolitis. Pediatrics. 1999;103(4 Pt 1):766-771.
58. Caplan MS, Simon D, Jilling T. The role of PAF, TLR, and
the inflammatory response in neonatal necrotizing enterocolitis. Semin
Pediatr Surg. 2005;14(3):145-151.
59.Caplan MS, Hedlund E, Adler L, Lickerman M, Hsueh
W. The platelet-activating factor receptor antagonist WEB 2170 prevents
neonatal necrotizing enterocolitis in rats. J Pediatr Gastroenterol
Nutr. 1997;24(3):296-301.
60. Caplan MS, Lickerman M, Adler L, Dietsch GN, Yu A. The role
of recombinant platelet-activating factor acetylhydrolase in a neonatal rat
model of necrotizing enterocolitis. Pediatr Res. 1997;42(6):779-783.
61. Dignass AU. Mechanisms and modulation of intestinal epithelial
repair. Inflamm Bowel Dis. 2001;7(1):68-77.
62. Koldovsky O, Sunshine P, Kretchmer N. Cellular migration
of intestinal epithelia in suckling and weaned rats. Nature. 1966;212(5068):1389-1390.
63. Anand RJ, Leaphart CL, Mollen KP, Hackam DJ. The role of
the intestinal barrier in the pathogenesis of necrotizing enterocolitis. Shock. 2007;27(2):124-133.
64. Leaphart CL, Qureshi F, Cetin S, et al. Interferon-gamma
inhibits intestinal restitution by preventing gap junction communication
between enterocytes. Gastroenterology. 2007;132(7):2395-2411.
65. Ford HR. Mechanism of nitric oxide-mediated intestinal barrier
failure: insight into the pathogenesis of necrotizing enterocolitis. J
Pediatr Surg. 2006;41(2):294-299.
66. Zhou Y, Wang Q, Evers BM, Chung DH. Signal transduction
pathways involved in oxidative stress-induced intestinal epithelial
cell apoptosis. Pediatr Res. 2005;58(6):1192-1197.
67. Ikeda H, Suzuki Y, Suzuki M, et al. Apoptosis is a major
mode of cell death caused by ischaemia and ischaemia/reperfusion
injury to the rat intestinal epithelium. Gut. 1998;42(4):530-537.
68. Kim JM, Eckmann L, Savidge TC, Lowe DC, Witthoft T, Kagnoff
MF. Apoptosis of human intestinal epithelial cells after bacterial
invasion. J Clin Invest. 1998;102(10):1815-1823.
69. Jilling T, Lu J, Jackson M, Caplan MS. Intestinal epithelial
apoptosis initiates gross bowel necrosis in an experimental rat
model of neonatal necrotizing enterocolitis. Pediatr Res. 2004;55(4):622-629.
70. Clark JA, Lane RH, Maclennan NK, et al. Epidermal growth
factor reduces intestinal apoptosis in an experimental model of
necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2005;288(4):G755-G762.
71. Insoft RM, Sanderson IR, Walker WA. Development of immune
function in the intestine and its role in neonatal diseases. Pediatr
Clin North Am. 1996;43(2):551-571.
72. Berseth CL. Gestational evolution of small intestine motility
in preterm and term infants. J Pediatr. 1989;115(4):646-651.
73. Milla PJ. Intestinal motility during ontogeny and intestinal
pseudo-obstruction in children. Pediatr Clin North Am. 1996;43(2):511-532.
74. Newburg DS, Walker WA. Protection of the neonate by the
innate immune system of developing gut and of human milk. Pediatr
Res. 2007;61(1):2-8.
75. Mallow EB, Harris A, Salzman N, et al. Human enteric defensins.
Gene structure and developmental expression. J Biol Chem. 1996;271(8):4038-4045.
76. Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins,
and the commensal microbiota: a hypothesis on intimate interplay at
the intestinal mucosa. Semin Immunol. 2007;19(2):70-83.
77. Reber KM, Nankervis CA, Nowicki PT. Newborn intestinal circulation.
Physiology and pathophysiology. Clin Perinatol. 2002;29(1):23-39.
78. Buckley NM, Brazeau P, Frasier ID, Gootman PM. Circulatory
effects of splanchnic nerve stimulation in developing swine. Am
J Physiol. 1985;248(1 Pt 2):H69-H74.
79. Nowicki PT. Ischemia and necrotizing enterocolitis: where,
when, and how. Semin Pediatr Surg. 2005;14(3):152-158.
80. Nowicki PT, Caniano DA, Hammond S, et al. Endothelial
nitric oxide synthase in human intestine resected for necrotizing
enterocolitis. J Pediatr. 2007;150(1):40-45.
81. Nowicki PT, Dunaway DJ, Nankervis CA, et al. Endothelin-1
in human intestine resected for necrotizing enterocolitis. J
Pediatr. 2005;146(6): 805-810.
82. Ito Y, Doelle SM, Clark JA, Halpern MD, McCuskey RS, Dvorak
B. Intestinal microcirculatory dysfunction during the development
of experimental necrotizing enterocolitis. Pediatr Res. 2007;61(2):180-184.
83. Kliegman RM, Walker WA, Yolken RH. Necrotizing enterocolitis:
research agenda for a disease of unknown etiology and pathogenesis. Pediatr
Res. 1993;34(6):701-708.
84. Harding D. Impact of common genetic variation on
neonatal disease and outcome. Arch Dis Child Fetal Neonatal
Ed. 2007;92(5):F408-F413.
85. Hack KE, Derks JB, Elias SG, et al. Increased perinatal
mortality and morbidity in monochorionic versus dichorionic twin
pregnancies: clinical implications of a large Dutch cohort study. BJOG. 2008;115(1):58-67.
86. Bhandari V, Bizzarro MJ, Shetty A, et al. Familial and genetic
susceptibility to major neonatal morbidities in preterm twins. Pediatrics. 2006;117(6):1901-1906.
87. Bokodi G, Derzbach L, Banyasz I, Tulassay T, Vasarhelyi
B. Association of interferon gamma T+874A and interleukin
12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory
support and perinatal complications in low birthweight neonates. Arch
Dis Child Fetal Neonatal Ed. 2007;92(1):F25-F29.
88. Heninger E, Treszl A, Kocsis I, Derfalvi B, Tulassay T,
Vasarhelyi B. Genetic variants of the interleukin-18 promoter region
(-607) influence the course of necrotising enterocolitis in very
low birth weight neonates. Eur J Pediatr. 2002;161
(7):410-411.
89. Treszl A, Kocsis I, Szathmari M, Schuler A, Tulassay T,
Vasarhelyi B. Genetic variants of the tumour necrosis factor-alpha
promoter gene do not influence the development of necrotizing enterocolitis. Acta
Paediatr. 2001;90(10):1182-1185.
90. Banyasz I, Bokodi G, Vasarhelyi B, et al. Genetic polymorphisms
for vascular endothelial growth factor in perinatal complications. Eur
Cytokine Netw. 2006;17(4):266-270.
91. Moonen RM, Paulussen AD, Souren NY, Kessels AG, Rubio-Gozalbo
ME, Villamor E. Carbamoyl phosphate synthetase polymorphisms as
a risk factor for necrotizing enterocolitis. Pediatr Res. 2007;62(2):188-190.
92. Habib Z, Arnaud B, Pascal DL, et al. CARD15/NOD2
is not a predisposing factor for necrotizing enterocolitis. Dig
Dis Sci. 2005;50(9):1684-1687.
93. Szebeni B, Szekeres R, Rusai K, et al. Genetic polymorphisms
of CD14, toll-like receptor 4, and caspase-recruitment domain 15
are not associated with necrotizing enterocolitis in very low birth
weight infants. J Pediatr Gastroenterol Nutr. 2006;42(1):27-31.
94. Kenet G, Maayan-Metzger A, Rosenberg N, et al. Thrombophilia
does not increase risk for neonatal complications in preterm infants. Thromb
Haemost. 2003;90(5):823-828.
95. Treszl A, Tulassay T, Vasarhelyi B. Genetic basis for necrotizing
enterocolitis: risk factors and their relations to genetic polymorphisms.
Front
Biosci. 2006;11:570-580.
[PubMed: 16146753]
96. Cobb BA, Carlo WA, Ambalavanan N. Gastric residuals and
their relationship to necrotizing enterocolitis in very low birth
weight infants. Pediatrics. 2004;113(1 Pt 1):50-53.
97. Aschner JL, Deluga KS, Metlay LA, Emmens RW, Hendricks-Munoz
KD. Spontaneous focal gastrointestinal perforation in very low birth weight
infants. J Pediatr. 1988;113(2):364-367.
98. Attridge JT, Clark R, Walker MW, Gordon PV. New insights
into spontaneous intestinal perforation using a national data set:
(1) SIP is associated with early
indomethacin exposure.
J Perinatol. 2006;26(2):93-99.
99. Gordon PV, Swanson JR, Attridge JT, Clark R. Emerging trends
in acquired neonatal intestinal disease: is it time to abandon Bell’s
criteria? J Perinatol. 2007;27(11):661-671.
100. Attridge JT, Clark R, Walker MW, Gordon PV. New insights
into spontaneous intestinal perforation using a national data set:
(2) two populations of patients with perforations. J Perinatol. 2006;26(3):185-188.
101. Kenton AB, O’Donovan D, Cass DL, et al. Severe
thrombocytopenia predicts outcome in neonates with necrotizing enterocolitis. J
Perinatol. 2005;25(1):14-20.
102. Kessler U, Mungnirandr A, Nelle M, Nimmo AF, Zachariou
Z, Berger S. A simple presurgical necrotizing enterocolitis-mortality
scoring system. J Perinatol. 2006;26(12):764-768.
103. Pourcyrous M, Korones SB, Yang W, Boulden TF, Bada HS.
C-reactive protein in the diagnosis, management, and prognosis of
neonatal necrotizing enterocolitis. Pediatrics. 2005;116(5):1064-1069.
104. Kosloske AM, Musemeche CA, Ball WS Jr, Ablin DS, Bhattacharyya
N. Necrotizing enterocolitis: value of radiographic findings to predict
outcome.
AJR Am J Roentgenol. 1988; 151(4):771-774.
[PubMed: 3262277]
105. Cikrit D, Mastandrea J, Grosfeld JL, West KW, Schreiner
RL. Significance of portal vein air in necrotizing enterocolitis:
analysis of 53 cases. J Pediatr Surg. 1985;20(4):425-430.
106. Molik KA, West KW, Rescorla FJ, Scherer LR, Engum SA, Grosfeld
JL. Portal venous air: the poor prognosis persists.
J Pediatr
Surg. 2001; 36(8):1143-1145.
[PubMed: 11479843]
107. Epelman M, Daneman A, Navarro OM, et al. Necrotizing enterocolitis:
review of state-of-the-art imaging findings with pathologic correlation. Radiographics. 2007;27(2):285-305.
108. Bell MJ TJ, Keating JP, Marshall R, Barton L, et al. Neonatal
Necrotizing enterocolitis: therapeutic decisions based upon clinical
staging.
Ann Surg. 1978;187:1-7.
[PubMed: 413500]
109. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment
based on staging criteria. Pediatr Clin North Am. 1986;33(1):179-201.
110. Ballance WA, Dahms BB, Shenker N, Kliegman
RM. Pathology of neonatal necrotizing enterocolitis: a ten-year
experience. J Pediatr. 1990; 117(1 Pt 2):S6-S13.
111. Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi
F. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic
concepts. Pediatr Dev Pathol. 2003;6(1):6-23.
112. Kosloske AM, Musemeche CA. Necrotizing enterocolitis of
the neonate. Clin Perinatol. 1989;16(1):97-111.
113. Faix RG, Polley TZ, Grasela TH. A randomized, controlled
trial of parenteral
clindamycin in neonatal necrotizing enterocolitis.
J
Pediatr. 1988;112(2):271-277.
114. Scheifele DW, Ginter GL, Olsen E, Fussell S, Pendray M.
Comparison of two antibiotic regimens for neonatal necrotizing enterocolitis. J Antimicrob
Chemother. 1987;20(3):421-429.
115. Dimmitt R, Moss L. Clinical Management of Necrotizing Enterocolitis. NeoReviews. 2001;2 (5):c110-c116.
116. Lee JS, Polin RA. Treatment and prevention of necrotizing
enterocolitis. Semin Neonatol. 2003;8(6):449-459.
117. Henry MC, Lawrence Moss R. Surgical therapy for necrotizing
enterocolitis: bringing evidence to the bedside. Semin Pediatr
Surg. 2005;14(3):181-190.
118. Sharma R, Tepas JJ 3rd, Hudak ML, et al. Neonatal
gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines
in sepsis and necrotizing enterocolitis. J Pediatr Surg. 2007;42(3):454-461.
119. Kosloske AM. Indications for operation in necrotizing enterocolitis
revisited. J Pediatr Surg. 1994;29(5):663-666.
120. Rowe MI, Reblock KK, Kurkchubasche AG, Healey PJ. Necrotizing
enterocolitis in the extremely low birth weight infant. J
Pediatr Surg. 1994;29(8):987-990; discussion 990-981.
121. Ein SH, Marshall DG, Girvan D. Peritoneal drainage under
local anesthesia for perforations from necrotizing enterocolitis. J
Pediatr Surg. 1977;12(6):963-967.
122. Camberos A, Patel K, Applebaum H. Laparotomy in very small
premature infants with necrotizing enterocolitis or focal intestinal
perforation: postoperative outcome. J Pediatr Surg. 2002;37(12):1692-1695.
123. Demestre X, Ginovart G, Figueras-Aloy J, et al. Peritoneal
drainage as primary management in necrotizing enterocolitis: a prospective study. J
Pediatr Surg. 2002;37(11):1534-1539.
124. Moss RL, Dimmitt RA, Henry MC, Geraghty N, Efron B. A meta-analysis
of peritoneal drainage versus laparotomy for perforated necrotizing
enterocolitis. J Pediatr Surg. 2001;36(8):1210-1213.
125. Moss RL, Dimmitt RA, Barnhart DC, et al. Laparotomy versus
peritoneal drainage for necrotizing enterocolitis and perforation. N Engl
J Med. 2006;354(21):2225-2234.
126. Flake A. Necrotizing enterocolitis in preterm infants. N
Engl J Med. 2006;354(21):2275-2276.
127. Bisquera JA, Cooper TR, Berseth CL. Impact of necrotizing
enterocolitis on length of stay and hospital charges in very low
birth weight infants. Pediatrics. 2002;109(3):423-428.
128. Hintz SR, Kendrick DE, Vohr BR, Poole WK, Higgins RD. Changes
in neurodevelopmental outcomes at 18 to 22 months’ corrected
age among infants of less than 25 weeks’ gestational age
born in 1993-1999. Pediatrics. 2005;115(6):1645-1651.
129. Salhab WA, Perlman JM, Silver L, Sue Broyles R. Necrotizing
enterocolitis and neurodevelopmental outcome in extremely low birth
weight infants <1000 g. J Perinatol. 2004;24(9):534-540.
130. Rees CM, Pierro A, Eaton S. Neurodevelopmental outcomes
of neonates with medically and surgically treated necrotizing enterocolitis. Arch
Dis Child Fetal Neonatal Ed. 2007;92(3):F193-F198.
131. Schulzke SM, Deshpande GC, Patole SK. Neurodevelopmental
outcomes of very low-birth-weight infants with necrotizing enterocolitis:
a systematic review of observational studies. Arch Pediatr
Adolesc Med. 2007;161(6):583-590.
132. Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental
and functional outcomes of extremely low birth weight infants in
the National Institute of Child Health and Human Development Neonatal
Research Network, 1993-1994. Pediatrics. 2000;105(6):1216-1226.
133. Warner B, Brown R, Crossman M, et al. Evidence-based care
guideline for medical management of very low birth weight infants
at risk for NEC. National Guideline Clearinghouse (NGC) Agency for
Health Care Research and Quality. US Department of Health and Human
Services.
http://www.guideline.gov/summary/summary.aspx?doc_id=10578.
Accessed April 21, 2009.
134. Bauer CR, Morrison JC, Poole WK, et al. A decreased
incidence of necrotizing enterocolitis after prenatal glucocorticoid
therapy. Pediatrics. 1984;73(5):682-688.
135. Halac E, Halac J, Begue EF, et al. Prenatal and postnatal
corticosteroid therapy to prevent neonatal necrotizing enterocolitis:
a controlled trial. J Pediatr. 1990;117(1 Pt 1):132-138.
136. Garite TJ, Rumney PJ, Briggs GG, et al. A randomized, placebo-controlled
trial of
betamethasone for the prevention of respiratory distress
syndrome at 24 to 28 weeks’ gestation.
Am J Obstet
Gynecol. 1992;166(2):646-651.
137. Gartner LM, Morton J, Lawrence RA, et al. Breastfeeding
and the use of human milk. Pediatrics. 2005;115(2):496-506.
138. Gross SJ. Growth and biochemical response of preterm infants
fed human milk or modified infant formula. N Engl J Med. 1983;308(5):237-241.
139. Lucas A, Cole TJ. Breast milk and neonatal necrotising
enterocolitis. Lancet. 1990;336 (8730):1519-1523.
140. Lucas A, Gore SM, Cole TJ, et al. Multicentre trial on
feeding low birthweight infants: effects of diet on early growth. Arch
Dis Child. 1984;59(8):722-730.
141. Schanler RJ, Lau C, Hurst NM, Smith EO. Randomized trial
of donor human milk versus preterm formula as substitutes for mothers’ own
milk in the feeding of extremely premature infants. Pediatrics. 2005;116(2):400-406.
142. Tyson JE, Lasky RE, Mize CE, et al. Growth, metabolic response,
and development in very-low-birth-weight infants fed banked human milk
or enriched formula. I. Neonatal findings. J Pediatr. 1983;103(1):95-104.
143. Quigley MA, Henderson G, Anthony MY, McGuire W. Formula
milk versus donor breast milk for feeding preterm or low birth weight infants. Cochrane
Database Syst Rev. 2007; (4):CD002971.
144. Hamosh M. Bioactive factors in human milk. Pediatr
Clin North Am. 2001;48(1):69-86.
145. Sisk PM, Lovelady CA, Dillard RG, Gruber KJ. Lactation
counseling for mothers of very low birth weight infants: effect
on maternal anxiety and infant intake of human milk. Pediatrics. 2006;117(1):e67-e75.
146. Berseth CL. Feeding strategies and necrotizing enterocolitis. Curr
Opin Pediatr. 2005;17(2):170-173.
147. Henderson G, Craig S, Brocklehurst P, McGuire W. Enteral
feeding regimens and necrotising enterocolitis in preterm infants:
multi-centre case-control study. Arch Dis Child Fetal Neonatal
Ed. 2007; doi:10.1136/adc.2007.119560.
148. Wiedmeier SE, Henry E, Baer VL, et al. Center differences
in NEC within one health-care system may depend on feeding protocol. Am
J Perinatol. 2008;25(1):5-12.
149. Patole SK, de Klerk N. Impact of standardised feeding regimens
on incidence of neonatal necrotising enterocolitis: a systematic
review and meta-analysis of observational studies. Arch
Dis Child Fetal Neonatal Ed. 2005; 90(2):F147-F151.
150. Brown EG, Sweet AY. Preventing necrotizing enterocolitis
in neonates. JAMA. 1978;240(22): 2452-2454.
151. Kamitsuka MD, Horton MK, Williams MA. The incidence of
necrotizing enterocolitis after introducing standardized feeding
schedules for infants between 1250 and 2500 grams and less than
35 weeks of gestation.
Pediatrics. 2000; 105(2):379-384.
[PubMed: 10654959]
152. Patole SK, Kadalraja R, Tuladhar R, Almonte R, Muller R,
Whitehall JS. Benefits of a standardised feeding regimen during
a clinical trial in preterm neonates. Int J Clin Pract. 2000;54(7):429-431.
153. Spritzer R, Koolen AM, Baerts W, Fetter WP, Lafeber HN,
Sauer PJ. A prolonged decline in the incidence of necrotizing enterocolitis
after the introduction of a cautious feeding regimen. Acta
Paediatr Scand. 1988;77(6):909-911.
154. LaGamma EF, Ostertag SG, Birenbaum H. Failure of delayed
oral feedings to prevent necrotizing enterocolitis. Results of study
in very-low-birth-weight neonates. Am J Dis Child. 1985;139(4):385-389.
155. Tyson JE, Kennedy KA. Trophic feedings for parenterally
fed infants. Cochrane Database Syst Rev. 2005;(3):CD000504.
156. Berseth CL, Bisquera JA, Paje VU. Prolonging small feeding
volumes early in life decreases the incidence of necrotizing enterocolitis
in very low birth weight infants. Pediatrics. 2003;111(3):529-534.
157. Kennedy KA, Tyson JE, Chamnanvanakij S. Rapid versus slow
rate of advancement of feedings for promoting growth and preventing necrotizing
enterocolitis in parenterally fed low-birth-weight infants. Cochrane
Database Syst Rev. 2000;(2):CD001241.
158. Davey AM, Wagner CL, Cox C, Kendig JW. Feeding premature
infants while low umbilical artery catheters are in place: a prospective, randomized
trial. J Pediatr. 1994;124(5 Pt 1):795-799.
159. Premji S, Chessell L. Continuous nasogastric milk feeding
versus intermittent bolus milk feeding for premature infants less
than 1500 grams. Cochrane Database Syst Rev. 2003;(1):CD001819.
160. McGuire W, McEwan P. Transpyloric versus gastric tube feeding
for preterm infants. Cochrane Database Syst Rev. 2007;(3):CD003487.
161. Araya M, Morreli L, Reid G, Sandres M, Stanton C. Joint
FAO/WHO Working Group Report on Drafting Guidelines for
the Evaluation of Probiotics in Food. London, UK: United Nations,
Food and Agriculture Organization, and World Health Organization;
2002.
162. Orrhage K, Nord CE. Factors controlling the bacterial colonization
of the intestine in breastfed infants. Acta Paediatr Suppl. 1999;88(430):47-57.
163. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli
FF. Probiotics feeding in prevention of urinary tract infection,
bacterial sepsis and necrotizing enterocolitis in preterm infants.
A prospective double-blind study. Biol Neonate. 2002;82(2):103-108.
164. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics
prevent necrotizing enterocolitis in very low birth weight neonates. J
Pediatr. 2005;147(2):192-196.
165. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the
incidence and severity of necrotizing enterocolitis in very low
birth weight infants. Pediatrics. 2005;115(1):1-4.
166. Alfaleh K, Bassler D. Probiotics for prevention of necrotizing
enterocolitis in preterm infants. Cochrane Database Syst
Rev. 2008;(1):CD005496.
167. Broughton RA, Gruber WC, Haffar AA, Baker CJ. Neonatal
meningitis due to Lactobacillus. Pediatr Infect Dis. 1983;2(5):382-384.
168. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota
J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005;115(1):178-181.
169. Thompson C, McCarter YS, Krause PJ, Herson VC. Lactobacillus
acidophilus sepsis in a neonate. J Perinatol. 2001;21(4):258-260.
170. Kliegman RM, Willoughby RE. Prevention of necrotizing enterocolitis
with probiotics. Pediatrics. 2005;115(1):171-172.
171. Bell EF. Preventing necrotizing enterocolitis: what works
and how safe?
Pediatrics. 2005; 115(1):173-174.
[PubMed: 15629996]
172. Bell E, Acarregui M. Restricted versus liberal water intake
for preventing morbidity and mortality in preterm infants. Cochrane
Database Syst Rev. 2008;(1):CD000503.
173. Eibl MM, Wolf HM, Furnkranz H, Rosenkranz A. Prevention
of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. N
Engl J Med. 1988;319(1):1-7.
174. Foster J, Cole M. Oral immunoglobulin for preventing necrotizing
enterocolitis in preterm and low birth-weight neonates. Cochrane Database
Syst Rev. 2004;(1):CD001816.
175. Fanaroff AA, Korones SB, Wright LL, et al. A controlled
trial of intravenous immune globulin to reduce nosocomial infections
in very-low-birth-weight infants. National Institute of Child Health
and Human Development Neonatal Research Network.
N Engl
J Med. 1994; 330(16):1107-1113.
[PubMed: 8133853]
176. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing
infection in preterm and/or low-birth-weight infants. Cochrane
Database Syst Rev. 2004;(1):CD000361.
177. Bury RG, Tudehope D. Enteral antibiotics for preventing
necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database
Syst Rev. 2001;(1):CD000405.
178. Tubman T, Thompson S, McGuire W. Glutamine supplementation
to prevent morbidity and mortality in preterm infants. Cochrane
Database Syst Rev. 2008;(1):CD001457.
179. Amin HJ, Zamora SA, McMillan DD, et al. Arginine supplementation
prevents necrotizing enterocolitis in the premature infant. J Pediatr. 2002;140(4):425-431.
180. Shah P, Shah V. Arginine supplementation for prevention
of necrotising enterocolitis in preterm infants. Cochrane
Database Syst Rev. 2007;(3):CD004339.